Vaxxas announced today that it was granted an exclusive license for a next-generation COVID-19 vaccine to be used with its delivery patch. Cambridge, Massachusetts-based Vaxxas received the license from The University of Texas at Austin for its HexaPro SARS-CoV-2 spike subunit vaccine. Get the full story at our sister site, Drug Delivery Business News.
University of Texas at Austin
Researchers at The University of Texas at Austin are touting an accurate antibody test for COVID-19 with lower costs than those currently in use. According to a news release, the test, developed in collaboration with Houston Methodist and other institutions, is more accurate than the standard antibody tests in use right now and can handle […]
Engineering students at the University of Texas at Austin have created a laparoscope designed like a 7-Eleven Slurpee straw that keeps a laparoscopic camera smudge-free. Laparoscopes are fiberoptic camera tools used during minimally invasive procedures. Surgeons use the cameras to see inside the body, but some times the lens can get smudged. The device, called […]
Researchers at the University of Texas at Austin have discovered a potential new way to eliminate biofilms to reduce the number of hospital-borne infections. Biofilms are a group of microorganisms that stick to a surface. Over time, the cells in the biofilm can grow and cause chronic infections and can even become resistant to antibiotics. […]
Researchers from the Cockrell School of Engineering at the University of Texas at Austin have developed a biodegradable capsule to deliver a protein therapy for hemophilia. The research, published in the International Journal of Pharmaceutics, could provide a cheaper, less painful alternative to injections or infusions. The capsule contains micro and nanoparticles which carry a protein […]